Human Patient-Derived Brain Tumor Models to Recapitulate Ependymoma Tumor Vasculature

被引:3
|
作者
Tang-Schomer, Min D. D. [1 ]
Bookland, Markus J. J. [2 ]
Sargent, Jack E. E. [3 ]
N. Jackvony, Taylor N. [1 ]
机构
[1] UConn Hlth, Dept Pediat, 263 Farmington Ave, Farmington, CT 06030 USA
[2] Connecticut Childrens Med Ctr, 282 Washington St, Hartford, CT 06106 USA
[3] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06030 USA
来源
BIOENGINEERING-BASEL | 2023年 / 10卷 / 07期
关键词
brain tumor model; tumor microenvironment; transcriptomics; cancer stem cells; tumor spheroid; neurosphere; homeobox;
D O I
10.3390/bioengineering10070840
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Despite in vivo malignancy, ependymoma lacks cell culture models, thus limiting therapy development. Here, we used a tunable three-dimensional (3D) culture system to approximate the ependymoma microenvironment for recapitulating a patient's tumor in vitro. Our data showed that the inclusion of VEGF in serum-free, mixed neural and endothelial cell culture media supported the in vitro growth of all four ependymoma patient samples. The growth was driven by Nestin and Ki67 double-positive cells in a putative cancer stem cell niche, which was manifested as rosette-looking clusters in 2D and spheroids in 3D. The effects of extracellular matrix (ECM) such as collagen or Matrigel superseded that of the media conditions, with Matrigel resulting in the greater enrichment of Nestin-positive cells. When mixed with endothelial cells, the 3D co-culture models developed capillary networks resembling the in vivo ependymoma vasculature. The transcriptomic analysis of two patient cases demonstrated the separation of in vitro cultures by individual patients, with one patient's culture samples closely clustered with the primary tumor tissue. While VEGF was found to be necessary for preserving the transcriptomic features of in vitro cultures, the presence of endothelial cells shifted the gene's expression patterns, especially genes associated with ECM remodeling. The homeobox genes were mostly affected in the 3D in vitro models compared to the primary tumor tissue and between different 3D formats. These findings provide a basis for understanding the ependymoma microenvironment and enabling the further development of patient-derived in vitro ependymoma models for personalized medicine.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas
    Hashizume, Rintaro
    Gupta, Nalin
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (01) : 98 - 103
  • [22] UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
    Cybula, Magdalena
    Moxley, Katherine
    Wang, Lin
    Wang, Luyao
    Bieniasz, Magdalena
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 84 - 84
  • [23] Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer
    Ehrenberg, Karl Roland
    Gao, Jianpeng
    Oppel, Felix
    Frank, Stephanie
    Kang, Na
    Kindinger, Tim
    Dieter, Sebastian M.
    Herbst, Friederike
    Moehrmann, Lino
    Dubash, Taronish D.
    Schulz, Erik R.
    Strakerjahn, Hendrik
    Giessler, Klara M.
    Weber, Sarah
    Oberlack, Ava
    Rief, Eva-Maria
    Strobel, Oliver
    Bergmann, Frank
    Lasitschka, Felix
    Weitz, Juergen
    Glimm, Hanno
    Ball, Claudia R.
    CELLS, 2019, 8 (02)
  • [24] Patient-Derived Xenograft Tumor Models: Overview and Relevance to IR
    Sheth, Rahul A.
    Perkons, Nicholas
    Dondossola, Eleonora
    Subudhi, Sumit K.
    Gade, Terence P.
    Tam, Alda L.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (06) : 880 - 882
  • [25] Framework models of tumor dormancy from patient-derived observations
    Klein, Christoph A.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) : 42 - 49
  • [26] Patient-derived tumor xenograft models for melanoma drug discovery
    Harris, Antoneicka L.
    Joseph, Richard W.
    Copland, John A.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 895 - 906
  • [27] Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
    Cassidy, John W.
    Caldas, Carlos
    Bruna, Alejandra
    CANCER RESEARCH, 2015, 75 (15) : 2963 - 2968
  • [28] A BIOBANK OF PATIENT-DERIVED MOLECULARLY CHARACTERIZED ORTHOTOPIC PEDIATRIC BRAIN TUMOR MODELS FOR PRECLINICAL RESEARCH
    Brabetz, Sebastian
    Groebner, Susanne N.
    Jaeger, Natalie
    Milde, Till
    Ecker, Jonas
    Selt, Florian
    Witt, Olaf
    Rusert, Jessica M.
    Koster, Jan
    Leary, Sarah E.
    Li, Xiao-Nan
    Wechsler-Reya, Robert J.
    Olson, James M.
    Pfister, Stefan M.
    Kool, Marcel
    NEURO-ONCOLOGY, 2018, 20 : 155 - 155
  • [29] PATIENT-DERIVED ORGANOIDS RECAPITULATE THE MOLECULAR LANDSCAPE OF PEDIATRIC BRAIN TUMORS
    Ferreira, Barbara
    Peixoto, Joana
    Ferro, Anabela
    Pinheiro, Jorge
    Silva, Roberto
    Pereira, Josue
    Oliveira, Joana
    Da Paula, Arnaud Cruz
    Soares, Paula
    Nunes, Susana
    Fernandes, Ana Paula
    da Costa, Maria Joao Gil
    Lima, Jorge
    NEURO-ONCOLOGY, 2024, 26
  • [30] Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma
    Boult, Jessica K. R.
    Apps, John R.
    Hoelsken, Annett
    Hutchinson, J. Ciaran
    Carreno, Gabriela
    Danielson, Laura S.
    Smith, Laura M.
    Baeuerle, Tobias
    Buslei, Rolf
    Buchfelder, Michael
    Virasami, Alex K.
    Koers, Alexander
    Arthurs, Owen J.
    Jacques, Thomas S.
    Chesler, Louis
    Martinez-Barbera, Juan Pedro
    Robinson, Simon P.
    BRAIN PATHOLOGY, 2018, 28 (04) : 475 - 483